• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVID-19 ANTIBODY COMPREHENSIVE TEST; REAGENT, CORONAVIRUS SEROLOGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVID-19 ANTIBODY COMPREHENSIVE TEST; REAGENT, CORONAVIRUS SEROLOGICAL Back to Search Results
Device Problems Product Quality Problem (1506); Inadequate Instructions for Non-Healthcare Professional (2956)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/13/2022
Event Type  malfunction  
Event Description
We have three members in our household (one of whom is not biologically related) who could not obtain enough blood to provide a sample sufficient for testing despite explicitly following all directions.We called the company (4u health); the co-founder, "(b)(6)," instructed us to run our hands under warm water and assured us that this remedy worked "99% of the time." all three of us made a subsequent attempt following this additional instruction and still could not obtain a sufficient sample.We have left multiple messages for the company since then and have not received a call back.We believe this product is not user-friendly to the average person and should not be marketed to the general public.
 
Event Description
Additional information received on 01/11/2022 for report mw5114159 to update procode to qko.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVID-19 ANTIBODY COMPREHENSIVE TEST
Type of Device
REAGENT, CORONAVIRUS SEROLOGICAL
MDR Report Key16103040
MDR Text Key306801375
Report NumberMW5114159
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial,Followup
Report Date 12/31/2022
3 Devices were Involved in the Event: 1   2   3  
1 Patient was Involved in the Event
Date FDA Received01/04/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date03/19/2023
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
ALFUZOSIN; AMOXICILLIN; ASPIRIN ; ATORVASTATIN ; CENTRUM SILVER; PLAVIX
Patient Age68 YR
Patient SexMale
Patient Weight79 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-